comparemela.com
Home
Live Updates
Matthieu Lamy - Breaking News
Pages:
Matthieu Lamy News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Ad Scientiam Launches Programs to Develop Digital Biomarkers for Chronic Neurological Diseases
PARIS, FRANCE, Feb. 28, 2023 (GLOBE NEWSWIRE) On Rare Disease Day, Ad Scientiam, a leader in digital biomarkers, announced the launch of two ambitious programs to develop and validate novel digital
France general
Dennis riedl
Saad zina
Linkedinand facebook
Guido sabatella
Paris brain institute
Rare disease day
Astrazeneca rare
Global medical lead
Matthieu lamy
Quantitative myasthenia gravis
Chief medical
Scientiam logo
Investegate |Ad Scientiam Announcements | Ad Scientiam: Ad Scientiam Launches Programs to Develop Digital Biomarkers for Chronic Neurological Diseases
Investegate announcements from Ad Scientiam, Ad Scientiam Launches Programs to Develop Digital Biomarkers for Chronic Neurological Diseases
France general
Saad zina
Guido sabatella
Paris brain institute
Develop digital biomarkers
Chronic neurological
Rare disease day
Astrazeneca rare
Global medical lead
Matthieu lamy
Quantitative myasthenia gravis
Chief medical
Investegate announcements
Investegate company announcements
Ad scientiam
Lobenewswire and globenewswire
vimarsana © 2020. All Rights Reserved.